Kendall Hunter
Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Artery | 33 | 2024 | 1030 | 3.960 |
Why?
| Hypertension, Pulmonary | 37 | 2023 | 1745 | 3.290 |
Why?
| Ventricular Dysfunction, Right | 14 | 2023 | 228 | 3.230 |
Why?
| Ventricular Function, Right | 21 | 2024 | 274 | 3.190 |
Why?
| Heart Ventricles | 23 | 2024 | 765 | 2.930 |
Why?
| Vascular Stiffness | 25 | 2023 | 464 | 2.410 |
Why?
| Models, Cardiovascular | 13 | 2020 | 190 | 1.760 |
Why?
| Pulmonary Circulation | 13 | 2022 | 416 | 1.470 |
Why?
| Stroke Volume | 15 | 2023 | 586 | 1.310 |
Why?
| Magnetic Resonance Imaging, Cine | 12 | 2023 | 184 | 1.250 |
Why?
| Blood Pressure | 12 | 2021 | 1728 | 1.070 |
Why?
| Arterial Pressure | 5 | 2019 | 118 | 0.990 |
Why?
| Hemodynamics | 16 | 2023 | 1081 | 0.970 |
Why?
| Vascular Resistance | 11 | 2022 | 367 | 0.970 |
Why?
| Echocardiography, Three-Dimensional | 2 | 2023 | 48 | 0.950 |
Why?
| Cardiac Catheterization | 13 | 2021 | 515 | 0.950 |
Why?
| Fontan Procedure | 6 | 2023 | 168 | 0.930 |
Why?
| Echocardiography | 10 | 2024 | 623 | 0.920 |
Why?
| Imaging, Three-Dimensional | 4 | 2013 | 533 | 0.850 |
Why?
| Phantoms, Imaging | 2 | 2014 | 137 | 0.810 |
Why?
| Magnetic Resonance Angiography | 4 | 2019 | 235 | 0.780 |
Why?
| Magnetic Resonance Imaging | 13 | 2024 | 3376 | 0.770 |
Why?
| Blood Flow Velocity | 8 | 2019 | 409 | 0.750 |
Why?
| Forecasting | 1 | 2021 | 358 | 0.650 |
Why?
| Heart Defects, Congenital | 5 | 2024 | 740 | 0.610 |
Why?
| Carotid Arteries | 3 | 2018 | 195 | 0.590 |
Why?
| Pulmonary Wedge Pressure | 1 | 2017 | 66 | 0.570 |
Why?
| Computer Simulation | 9 | 2019 | 939 | 0.550 |
Why?
| Aorta, Thoracic | 6 | 2023 | 260 | 0.510 |
Why?
| Echinococcosis, Pulmonary | 1 | 2015 | 7 | 0.500 |
Why?
| Collagen | 6 | 2014 | 429 | 0.490 |
Why?
| Elastic Modulus | 4 | 2013 | 123 | 0.470 |
Why?
| Aorta | 6 | 2020 | 404 | 0.460 |
Why?
| Child | 33 | 2023 | 20655 | 0.450 |
Why?
| Hypoxia | 5 | 2024 | 1036 | 0.420 |
Why?
| Male | 51 | 2025 | 62857 | 0.420 |
Why?
| Fetal Growth Retardation | 3 | 2013 | 543 | 0.420 |
Why?
| Portal Vein | 1 | 2014 | 105 | 0.410 |
Why?
| Cattle | 10 | 2023 | 960 | 0.400 |
Why?
| Heart-Assist Devices | 4 | 2021 | 537 | 0.400 |
Why?
| Industry | 1 | 2013 | 63 | 0.400 |
Why?
| Pulmonary Valve Insufficiency | 1 | 2012 | 40 | 0.390 |
Why?
| Tetralogy of Fallot | 1 | 2012 | 78 | 0.390 |
Why?
| Placental Insufficiency | 1 | 2013 | 111 | 0.370 |
Why?
| Humans | 66 | 2024 | 128417 | 0.360 |
Why?
| Diagnostic Imaging | 1 | 2014 | 330 | 0.360 |
Why?
| Adolescent | 25 | 2023 | 20179 | 0.350 |
Why?
| Female | 46 | 2025 | 68153 | 0.350 |
Why?
| Myocardial Contraction | 4 | 2020 | 330 | 0.340 |
Why?
| Blood Pressure Determination | 2 | 2008 | 148 | 0.340 |
Why?
| Extracellular Matrix | 5 | 2021 | 495 | 0.340 |
Why?
| Elasticity | 6 | 2015 | 199 | 0.340 |
Why?
| Pulse Wave Analysis | 6 | 2023 | 248 | 0.330 |
Why?
| Predictive Value of Tests | 9 | 2023 | 1935 | 0.330 |
Why?
| Ventricular Function, Left | 5 | 2023 | 524 | 0.330 |
Why?
| Heart Failure | 5 | 2023 | 2145 | 0.330 |
Why?
| Ultrasonography | 1 | 2013 | 710 | 0.320 |
Why?
| Stress, Physiological | 1 | 2012 | 410 | 0.300 |
Why?
| Hypoplastic Left Heart Syndrome | 2 | 2020 | 116 | 0.300 |
Why?
| Aortic Diseases | 2 | 2021 | 114 | 0.300 |
Why?
| Fetus | 1 | 2013 | 760 | 0.300 |
Why?
| Image Processing, Computer-Assisted | 3 | 2021 | 735 | 0.300 |
Why?
| Retrospective Studies | 18 | 2023 | 14454 | 0.290 |
Why?
| Image Interpretation, Computer-Assisted | 4 | 2018 | 254 | 0.290 |
Why?
| Stress, Mechanical | 9 | 2019 | 463 | 0.290 |
Why?
| Infant | 12 | 2021 | 8914 | 0.280 |
Why?
| Elastin | 6 | 2015 | 77 | 0.280 |
Why?
| Pulmonary Disease, Chronic Obstructive | 3 | 2021 | 945 | 0.270 |
Why?
| Case-Control Studies | 13 | 2019 | 3328 | 0.270 |
Why?
| Heart Septal Defects | 1 | 2006 | 7 | 0.270 |
Why?
| Cardiac Output | 4 | 2020 | 154 | 0.270 |
Why?
| Ventricular Dysfunction, Left | 3 | 2019 | 383 | 0.260 |
Why?
| Vasomotor System | 1 | 2006 | 43 | 0.260 |
Why?
| Child, Preschool | 14 | 2023 | 10384 | 0.240 |
Why?
| Regional Blood Flow | 4 | 2021 | 459 | 0.240 |
Why?
| Follow-Up Studies | 5 | 2021 | 4892 | 0.230 |
Why?
| Reproducibility of Results | 7 | 2018 | 3020 | 0.230 |
Why?
| Tomography, X-Ray Computed | 2 | 2018 | 2523 | 0.230 |
Why?
| Heart Transplantation | 2 | 2023 | 710 | 0.220 |
Why?
| Animals | 22 | 2025 | 34479 | 0.220 |
Why?
| Arteries | 2 | 2018 | 262 | 0.220 |
Why?
| Models, Biological | 1 | 2011 | 1691 | 0.220 |
Why?
| Myocardium | 3 | 2023 | 965 | 0.210 |
Why?
| Patient-Specific Modeling | 3 | 2020 | 39 | 0.210 |
Why?
| Materials Testing | 2 | 2017 | 346 | 0.210 |
Why?
| Electrocardiography | 2 | 2023 | 604 | 0.200 |
Why?
| Endothelial Cells | 3 | 2023 | 698 | 0.200 |
Why?
| Prospective Studies | 9 | 2021 | 7036 | 0.200 |
Why?
| Umbilical Arteries | 2 | 2013 | 51 | 0.200 |
Why?
| Severity of Illness Index | 6 | 2019 | 2721 | 0.200 |
Why?
| Perfusion Imaging | 2 | 2019 | 56 | 0.190 |
Why?
| Sensitivity and Specificity | 4 | 2018 | 1815 | 0.190 |
Why?
| Assisted Circulation | 1 | 2021 | 25 | 0.190 |
Why?
| Exercise | 2 | 2024 | 1929 | 0.180 |
Why?
| Adipose Tissue | 1 | 2025 | 589 | 0.180 |
Why?
| Arrhythmias, Cardiac | 1 | 2023 | 316 | 0.180 |
Why?
| Glycopeptides | 1 | 2021 | 44 | 0.180 |
Why?
| Natriuretic Peptide, Brain | 1 | 2021 | 99 | 0.170 |
Why?
| Cardiovascular Diseases | 2 | 2023 | 1999 | 0.170 |
Why?
| Ventricular Pressure | 1 | 2019 | 43 | 0.170 |
Why?
| Disease Models, Animal | 7 | 2023 | 3937 | 0.160 |
Why?
| Peptide Fragments | 2 | 2021 | 684 | 0.160 |
Why?
| Oxygen Consumption | 2 | 2024 | 669 | 0.160 |
Why?
| Age Factors | 5 | 2019 | 3103 | 0.160 |
Why?
| Lung | 5 | 2015 | 3743 | 0.150 |
Why?
| Marfan Syndrome | 1 | 2018 | 40 | 0.150 |
Why?
| Cardiac Surgical Procedures | 1 | 2024 | 490 | 0.150 |
Why?
| Sheep | 4 | 2014 | 828 | 0.150 |
Why?
| Microcirculation | 2 | 2016 | 137 | 0.150 |
Why?
| Neuroendocrine Cells | 1 | 2018 | 32 | 0.150 |
Why?
| Turner Syndrome | 1 | 2018 | 51 | 0.150 |
Why?
| Models, Theoretical | 2 | 2013 | 542 | 0.150 |
Why?
| Prognosis | 5 | 2019 | 3772 | 0.150 |
Why?
| Cardiorespiratory Fitness | 1 | 2018 | 49 | 0.140 |
Why?
| Thermodilution | 1 | 2017 | 13 | 0.140 |
Why?
| Glucagon-Like Peptide-1 Receptor | 1 | 2018 | 91 | 0.140 |
Why?
| Echocardiography, Doppler | 1 | 2018 | 108 | 0.140 |
Why?
| Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 90 | 0.140 |
Why?
| ROC Curve | 2 | 2015 | 500 | 0.140 |
Why?
| Aortic Coarctation | 1 | 2018 | 82 | 0.140 |
Why?
| Shear Strength | 3 | 2018 | 67 | 0.140 |
Why?
| Algorithms | 4 | 2019 | 1618 | 0.130 |
Why?
| Hemorheology | 1 | 2016 | 21 | 0.130 |
Why?
| Glycocalyx | 1 | 2016 | 19 | 0.130 |
Why?
| Arterioles | 1 | 2016 | 41 | 0.130 |
Why?
| Pressure | 2 | 2019 | 240 | 0.130 |
Why?
| Biomimetic Materials | 1 | 2017 | 71 | 0.130 |
Why?
| Adaptation, Physiological | 2 | 2018 | 514 | 0.130 |
Why?
| Capillaries | 1 | 2016 | 92 | 0.130 |
Why?
| Physical Conditioning, Animal | 1 | 2018 | 230 | 0.130 |
Why?
| Nitric Oxide | 1 | 2021 | 882 | 0.120 |
Why?
| Principal Component Analysis | 3 | 2023 | 183 | 0.120 |
Why?
| Compliance | 2 | 2012 | 44 | 0.120 |
Why?
| Familial Primary Pulmonary Hypertension | 4 | 2021 | 183 | 0.120 |
Why?
| Diabetes Mellitus, Type 1 | 2 | 2022 | 3624 | 0.120 |
Why?
| Myocytes, Smooth Muscle | 1 | 2017 | 245 | 0.120 |
Why?
| Area Under Curve | 1 | 2015 | 279 | 0.120 |
Why?
| Signal Processing, Computer-Assisted | 2 | 2023 | 143 | 0.120 |
Why?
| Animals, Newborn | 3 | 2015 | 803 | 0.120 |
Why?
| Endotoxins | 1 | 2015 | 216 | 0.120 |
Why?
| Young Adult | 8 | 2021 | 12312 | 0.120 |
Why?
| Tissue Scaffolds | 1 | 2017 | 199 | 0.110 |
Why?
| Software | 2 | 2023 | 608 | 0.110 |
Why?
| Image Enhancement | 1 | 2015 | 163 | 0.110 |
Why?
| Pulsatile Flow | 1 | 2014 | 59 | 0.110 |
Why?
| Adventitia | 1 | 2014 | 42 | 0.110 |
Why?
| Bronchi | 1 | 2015 | 240 | 0.110 |
Why?
| Contrast Media | 1 | 2017 | 387 | 0.110 |
Why?
| Muscle, Smooth, Vascular | 1 | 2017 | 417 | 0.110 |
Why?
| Cardiography, Impedance | 1 | 2013 | 8 | 0.110 |
Why?
| Time Factors | 4 | 2021 | 6482 | 0.110 |
Why?
| Toll-Like Receptor 2 | 1 | 2014 | 110 | 0.110 |
Why?
| Aorta, Abdominal | 1 | 2013 | 42 | 0.110 |
Why?
| Oscillometry | 1 | 2013 | 37 | 0.110 |
Why?
| Precision Medicine | 1 | 2017 | 384 | 0.110 |
Why?
| Persistent Fetal Circulation Syndrome | 1 | 2014 | 136 | 0.100 |
Why?
| Pilot Projects | 3 | 2021 | 1563 | 0.100 |
Why?
| Polymers | 1 | 2017 | 471 | 0.100 |
Why?
| Ultrasonography, Doppler, Color | 2 | 2010 | 37 | 0.100 |
Why?
| Middle Aged | 9 | 2021 | 30889 | 0.100 |
Why?
| Vasodilation | 3 | 2025 | 464 | 0.100 |
Why?
| Vitamin D | 1 | 2015 | 380 | 0.100 |
Why?
| Equipment Design | 1 | 2014 | 518 | 0.100 |
Why?
| Lung Diseases, Interstitial | 1 | 2018 | 593 | 0.100 |
Why?
| Models, Statistical | 1 | 2015 | 621 | 0.100 |
Why?
| Feasibility Studies | 1 | 2015 | 860 | 0.090 |
Why?
| Reference Values | 2 | 2017 | 776 | 0.090 |
Why?
| Elastic Tissue | 1 | 2011 | 8 | 0.090 |
Why?
| Fibrillar Collagens | 1 | 2011 | 14 | 0.090 |
Why?
| Linear Models | 2 | 2018 | 813 | 0.090 |
Why?
| Pre-Eclampsia | 1 | 2013 | 185 | 0.090 |
Why?
| Rats, Wistar | 2 | 2025 | 397 | 0.090 |
Why?
| Pregnancy | 5 | 2015 | 6357 | 0.090 |
Why?
| MicroRNAs | 1 | 2017 | 677 | 0.090 |
Why?
| Ultrasonography, Doppler, Pulsed | 1 | 2010 | 7 | 0.090 |
Why?
| NF-kappa B | 1 | 2014 | 649 | 0.090 |
Why?
| Biomarkers | 2 | 2021 | 3880 | 0.080 |
Why?
| Rats | 4 | 2025 | 5165 | 0.080 |
Why?
| Biomechanical Phenomena | 4 | 2017 | 778 | 0.080 |
Why?
| Vasodilator Agents | 1 | 2011 | 321 | 0.080 |
Why?
| Uncertainty | 1 | 2010 | 114 | 0.080 |
Why?
| Ultrasonics | 1 | 2009 | 47 | 0.080 |
Why?
| Exercise Test | 2 | 2024 | 613 | 0.080 |
Why?
| Microbubbles | 1 | 2009 | 48 | 0.080 |
Why?
| Ventricular Remodeling | 2 | 2023 | 254 | 0.080 |
Why?
| Hypertrophy, Right Ventricular | 2 | 2023 | 133 | 0.080 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2023 | 2429 | 0.080 |
Why?
| Postoperative Complications | 1 | 2020 | 2485 | 0.080 |
Why?
| Mechanotransduction, Cellular | 2 | 2023 | 110 | 0.070 |
Why?
| Fibrosis | 2 | 2021 | 512 | 0.070 |
Why?
| Logistic Models | 2 | 2015 | 1974 | 0.070 |
Why?
| Reference Standards | 1 | 2008 | 168 | 0.070 |
Why?
| Risk Factors | 3 | 2017 | 9704 | 0.070 |
Why?
| Ultrasonography, Doppler | 1 | 2008 | 121 | 0.070 |
Why?
| Electric Impedance | 1 | 2007 | 101 | 0.070 |
Why?
| Probability | 1 | 2007 | 305 | 0.070 |
Why?
| Adipose Tissue, Brown | 1 | 2025 | 51 | 0.060 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2025 | 197 | 0.060 |
Why?
| Chronic Disease | 1 | 2010 | 1705 | 0.050 |
Why?
| Protein-Losing Enteropathies | 1 | 2023 | 10 | 0.050 |
Why?
| Disease Progression | 3 | 2018 | 2602 | 0.050 |
Why?
| Treatment Outcome | 2 | 2018 | 10151 | 0.050 |
Why?
| Hypertension | 2 | 2012 | 1235 | 0.050 |
Why?
| Bromocriptine | 1 | 2022 | 28 | 0.050 |
Why?
| Glycosaminoglycans | 2 | 2013 | 84 | 0.050 |
Why?
| Cross-Sectional Studies | 3 | 2019 | 5039 | 0.050 |
Why?
| Matrix Metalloproteinases, Secreted | 1 | 2021 | 11 | 0.050 |
Why?
| Long Term Adverse Effects | 1 | 2021 | 11 | 0.050 |
Why?
| ADAMTS4 Protein | 1 | 2021 | 15 | 0.050 |
Why?
| Temperature | 1 | 2025 | 625 | 0.050 |
Why?
| Heart Murmurs | 1 | 2021 | 12 | 0.050 |
Why?
| Endothelium-Dependent Relaxing Factors | 1 | 2021 | 16 | 0.050 |
Why?
| Cross-Over Studies | 1 | 2022 | 513 | 0.040 |
Why?
| Vascular Remodeling | 1 | 2021 | 181 | 0.040 |
Why?
| Coronary Circulation | 1 | 2020 | 137 | 0.040 |
Why?
| Dimensional Measurement Accuracy | 1 | 2019 | 13 | 0.040 |
Why?
| Administration, Inhalation | 1 | 2021 | 661 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2021 | 429 | 0.040 |
Why?
| Overweight | 1 | 2023 | 524 | 0.040 |
Why?
| Mitochondria | 1 | 2025 | 848 | 0.040 |
Why?
| Rabbits | 1 | 2019 | 758 | 0.040 |
Why?
| Pediatrics | 1 | 2006 | 1046 | 0.040 |
Why?
| Rats, Sprague-Dawley | 2 | 2015 | 2239 | 0.040 |
Why?
| Diastole | 1 | 2018 | 148 | 0.040 |
Why?
| Comparative Effectiveness Research | 1 | 2019 | 146 | 0.040 |
Why?
| Heart Failure, Diastolic | 1 | 2018 | 21 | 0.040 |
Why?
| Hyperplasia | 1 | 2018 | 170 | 0.040 |
Why?
| Mitochondria, Heart | 1 | 2018 | 92 | 0.040 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 96 | 0.040 |
Why?
| Electrophysiologic Techniques, Cardiac | 1 | 2018 | 76 | 0.040 |
Why?
| Rare Diseases | 1 | 2018 | 101 | 0.040 |
Why?
| Postoperative Period | 1 | 2018 | 324 | 0.040 |
Why?
| Immunohistochemistry | 1 | 2021 | 1664 | 0.030 |
Why?
| Aftercare | 1 | 2019 | 206 | 0.030 |
Why?
| Vasoconstriction | 1 | 2018 | 185 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 2018 | 418 | 0.030 |
Why?
| Dilatation, Pathologic | 1 | 2017 | 60 | 0.030 |
Why?
| Heart Valve Diseases | 1 | 2018 | 151 | 0.030 |
Why?
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 101 | 0.030 |
Why?
| Activities of Daily Living | 1 | 2020 | 384 | 0.030 |
Why?
| Education | 1 | 2017 | 100 | 0.030 |
Why?
| Blood Viscosity | 1 | 2016 | 16 | 0.030 |
Why?
| Proteomics | 1 | 2023 | 1009 | 0.030 |
Why?
| Clinical Decision-Making | 1 | 2019 | 304 | 0.030 |
Why?
| Heart | 1 | 2020 | 635 | 0.030 |
Why?
| Exercise Tolerance | 1 | 2018 | 268 | 0.030 |
Why?
| Capillary Permeability | 1 | 2016 | 131 | 0.030 |
Why?
| Respiratory Physiological Phenomena | 1 | 2015 | 30 | 0.030 |
Why?
| Microfluidic Analytical Techniques | 1 | 2016 | 73 | 0.030 |
Why?
| Risk | 1 | 2018 | 853 | 0.030 |
Why?
| Aortic Valve | 1 | 2018 | 345 | 0.030 |
Why?
| Myocardial Ischemia | 1 | 2017 | 248 | 0.030 |
Why?
| Postoperative Care | 1 | 2017 | 241 | 0.030 |
Why?
| Analysis of Variance | 1 | 2018 | 1269 | 0.030 |
Why?
| Demography | 1 | 2015 | 277 | 0.030 |
Why?
| Aged | 3 | 2019 | 21953 | 0.030 |
Why?
| Hematocrit | 1 | 2014 | 93 | 0.030 |
Why?
| Tricuspid Valve | 1 | 2014 | 27 | 0.030 |
Why?
| Embryo, Mammalian | 1 | 2014 | 226 | 0.030 |
Why?
| Phosphatidylcholines | 1 | 2014 | 146 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2014 | 312 | 0.030 |
Why?
| Cardiomyopathies | 1 | 2017 | 335 | 0.030 |
Why?
| Altitude Sickness | 1 | 2014 | 137 | 0.030 |
Why?
| Infant, Newborn | 2 | 2014 | 5687 | 0.020 |
Why?
| Survival Rate | 1 | 2017 | 1869 | 0.020 |
Why?
| Toll-Like Receptor 4 | 1 | 2014 | 262 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2014 | 571 | 0.020 |
Why?
| Adult | 3 | 2024 | 35299 | 0.020 |
Why?
| Up-Regulation | 1 | 2014 | 825 | 0.020 |
Why?
| Mice | 2 | 2021 | 16602 | 0.020 |
Why?
| Erythrocytes | 1 | 2016 | 672 | 0.020 |
Why?
| Hospitals, Pediatric | 1 | 2014 | 505 | 0.020 |
Why?
| Obesity | 1 | 2023 | 2858 | 0.020 |
Why?
| Species Specificity | 1 | 2011 | 568 | 0.020 |
Why?
| Gestational Age | 1 | 2012 | 867 | 0.020 |
Why?
| Cells, Cultured | 1 | 2017 | 4001 | 0.020 |
Why?
| Hyperbaric Oxygenation | 1 | 2008 | 38 | 0.020 |
Why?
| Tunica Media | 1 | 2007 | 37 | 0.020 |
Why?
| Structure-Activity Relationship | 1 | 2008 | 530 | 0.020 |
Why?
| Finite Element Analysis | 1 | 2007 | 72 | 0.020 |
Why?
| Tunica Intima | 1 | 2007 | 80 | 0.020 |
Why?
| Protein Conformation | 1 | 2008 | 852 | 0.020 |
Why?
| Cell Proliferation | 1 | 2012 | 2344 | 0.010 |
Why?
| Radiography | 1 | 2007 | 859 | 0.010 |
Why?
| Mice, Inbred C57BL | 1 | 2014 | 5272 | 0.010 |
Why?
| Colorado | 1 | 2014 | 4375 | 0.010 |
Why?
| Research Design | 1 | 2010 | 1036 | 0.010 |
Why?
| Inflammation | 1 | 2014 | 2654 | 0.010 |
Why?
| United States | 1 | 2017 | 13830 | 0.010 |
Why?
|
|
Hunter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|